Concepedia
Statistics
Publications
14
Citations
11.3K
Authors
3
Location
New York, United States
Also known as MGFA
Myasthenia Gravis Foundation of America is a nonprofit institution in New York, United States known for clinical trials, pharmacotherapy, and pharmacology.
Top concepts
MedicinePharmacologyClinical TrialsPharmacotherapyClinical Epidemiology
Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient’s Perspective: A Qualitative Study
Kristi Jackson, Anju Parthan, Miranda Lauher-Charest et al. · Neurology and Therapy · 2022 · 52 citations · Full text
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study
Pushpa Narayanaswami, Donald B. Sanders, Laine Thomas et al. · The Lancet Neurology · 2024 · 44 citations
Mycophenolate Mofetil, Clinical Epidemiology, Clinical Trials +5
Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)
Sonia Berrih‐Aknin, Kristl G. Claeys, Nancy Law et al. · BMJ Open · 2021 · 17 citations · Full text
Identifying a patient‐centered outcome measure for a comparative effectiveness treatment trial in myasthenia gravis
Pushpa Narayanaswami, Donald B. Sanders, Kathie Bibeau et al. · Muscle & Nerve · 2021 · 11 citations
1–4 of 14
Myasthenia Gravis Foundation of America, United States
4 publications · 58 citations
2
h-index
4 publications · 55 citations
5 publications · 59 citations
1–3 of 3